BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14600368)

  • 1. Interactions of cholesterol with cyclodextrins in aqueous solution.
    Nishijo J; Moriyama S; Shiota S
    Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1253-7. PubMed ID: 14600368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of heptakis (2,3,6-tri-O-methyl)-beta-cyclodextrin with cholesterol in aqueous solution.
    Nishijo J; Moriyama S; Shiota S; Kamigauchi M; Sugiura M
    Chem Pharm Bull (Tokyo); 2004 Dec; 52(12):1405-10. PubMed ID: 15577234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of 6-p-toluidinylnaphthalene-2-sulfonate with beta-cyclodextrin.
    Nishijo J; Nagai M; Yasuda M; Ohno E; Ushiroda Y
    J Pharm Sci; 1995 Dec; 84(12):1420-6. PubMed ID: 8748323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fexofenadine/cyclodextrin inclusion complexation: phase solubility, thermodynamic, physicochemical, and computational analysis.
    Omari MM; Badwan AA; Zughul MB; Eric J; Davies D
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1205-15. PubMed ID: 18058317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of L-tryptophan with alpha-cyclodextrin: studies with calorimetry and proton nuclear magnetic resonance spectroscopy.
    Nishijo J; Tsuchitani M
    J Pharm Sci; 2001 Feb; 90(2):134-40. PubMed ID: 11169530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyclodextrins in solution.
    Bettinetti G; Melani F; Mura P; Monnanni R; Giordano F
    J Pharm Sci; 1991 Dec; 80(12):1162-70. PubMed ID: 1815076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical properties of thermodynamic quantities for cyclodextrin complex formation.
    Burnette RR; Connors KA
    J Pharm Sci; 2000 Nov; 89(11):1389-94. PubMed ID: 11015684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complex of 8-anilinonaphthalene-1-sulfonate with beta-cyclodextrin.
    Nishijo J; Nagai M
    J Pharm Sci; 1991 Jan; 80(1):58-62. PubMed ID: 1849574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of cyclodextrins with DPPC liposomes. Differential scanning calorimetry studies.
    Nishijo J; Mizuno H
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):120-4. PubMed ID: 9468643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic study on the effects of beta-cyclodextrin inclusion with berberine.
    Yu JS; Wei FD; Gao W; Zhao CC
    Spectrochim Acta A Mol Biomol Spectrosc; 2002 Jan; 58(2):249-56. PubMed ID: 11808730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies.
    Al Omari MM; Zughul MB; Davies JE; Badwan AA
    J Pharm Biomed Anal; 2006 Jun; 41(3):857-65. PubMed ID: 16527440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics of propylparaben/beta-cyclodextrin inclusion complexes.
    Zughul MB; al-Omari M; Badwan AA
    Pharm Dev Technol; 1998 Feb; 3(1):43-53. PubMed ID: 9532599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of piceatannol, a naturally occurring hydroxylated analogue of resveratrol, by natural and modified cyclodextrins.
    Matencio A; García-Carmona F; López-Nicolás JM
    Food Funct; 2016 May; 7(5):2367-73. PubMed ID: 27142512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
    Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
    J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of cyclodextrins with dipalmitoyl, distearoyl, and dimyristoyl phosphatidyl choline liposomes. A study by leakage of carboxyfluorescein in inner aqueous phase of unilamellar liposomes.
    Nishijo J; Shiota S; Mazima K; Inoue Y; Mizuno H; Yoshida J
    Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):48-52. PubMed ID: 10705474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of the complexation mechanism between (+)-usnic acid and cyclodextrins studied by isothermal titration calorimetry and phase-solubility diagram experiments.
    Segura-Sanchez F; Bouchemal K; Lebas G; Vauthier C; Santos-Magalhaes NS; Ponchel G
    J Mol Recognit; 2009; 22(3):232-41. PubMed ID: 19153981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel behavior of O-methylated beta-cyclodextrins in inclusion of meso-tetraarylporphyrins.
    Kano K; Nishiyabu R; Doi R
    J Org Chem; 2005 Apr; 70(9):3667-73. PubMed ID: 15845005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and theoretical studies on the inclusion complexation of syringic acid with alpha-, beta-, gamma- and heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
    Song le X; Wang HM; Xu P; Yang Y; Zhang ZQ
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):468-74. PubMed ID: 18379092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility of cyclomaltooligosaccharides (cyclodextrins) in H2O and D2O: a comparative study.
    Sabadini E; Cosgrove T; Egídio Fdo C
    Carbohydr Res; 2006 Feb; 341(2):270-4. PubMed ID: 16325788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion complexes of quercetin with three β-cyclodextrins derivatives at physiological pH: spectroscopic study and antioxidant activity.
    Liu M; Dong L; Chen A; Zheng Y; Sun D; Wang X; Wang B
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():854-60. PubMed ID: 23892509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.